Interplay of protein misfolding pathway and unfolded-protein response in acute promyelocytic leukemia
- PMID: 20653512
- DOI: 10.1586/epr.10.38
Interplay of protein misfolding pathway and unfolded-protein response in acute promyelocytic leukemia
Abstract
Protein misfolding has traditionally been linked to the pathogenesis of various neurodegenerative diseases. However, emerging evidence from various laboratories, including ours, suggests that protein misfolding may also play a fundamental role in some malignancies, particularly those caused by fusion oncoprotein generated from chromosomal translocation. Promyelocytic leukemia (PML) fused to the retinoic acid receptor (RAR) is a fusion oncoprotein linked to the transformation of acute promyelocytic leukemia (APL), and is not only a misfolded protein itself, but also promotes misfolding of nuclear receptor corepressor (N-CoR) protein, a corepressor essential for the growth-suppressive function of several tumor-suppressor proteins. PML-RAR promotes misfolding of N-CoR by inducing aberrant post-translational modification, which destabilizes its core and promotes instability. Misfolded N-CoR, thus, contributes to differentiation arrest and survival of APL cells through loss-of-function and aberrant gain-of-function properties. Therapeutic restoration of N-CoR conformation and function with conformation-modifying agents not only releases this differentiation arrest but also sensitizes APL cells to programmed cell death. These findings illustrate the potential of the misfolded N-CoR protein as a conformation-based drugable molecular target for APL, and highlights the promise of various conformation-modifying agents as novel therapeutics for APL. Protein conformational rearrangement, resulting from an inherited or acquired genetic alteration, could be a common pathological phenomenon contributing to transformation in different types of leukemias and solid tumors and, therefore, could serve as a common ground for designing a unifying diagnostic as well as therapeutic approach for a widely diverse disease such as cancer. To that end, APL could serve as a model for the development of a novel conformation-based therapeutic approach for other malignant diseases.
Similar articles
-
Cleavage of misfolded nuclear receptor corepressor confers resistance to unfolded protein response-induced apoptosis.Cancer Res. 2006 Oct 15;66(20):9903-12. doi: 10.1158/0008-5472.CAN-06-0002. Cancer Res. 2006. PMID: 17047052
-
Therapeutic targeting of nuclear receptor corepressor misfolding in acute promyelocytic leukemia cells with genistein.Mol Cancer Ther. 2007 Aug;6(8):2240-8. doi: 10.1158/1535-7163.MCT-06-0705. Mol Cancer Ther. 2007. PMID: 17699721
-
Curcumin sensitizes acute promyelocytic leukemia cells to unfolded protein response-induced apoptosis by blocking the loss of misfolded N-CoR protein.Mol Cancer Res. 2011 Jul;9(7):878-88. doi: 10.1158/1541-7786.MCR-10-0545. Epub 2011 May 20. Mol Cancer Res. 2011. PMID: 21602299
-
[Mechanism of action of retinoids in a new therapeutic approach to acute promyelocytic leukemia].Bull Cancer. 1992;79(7):697-704. Bull Cancer. 1992. PMID: 1334741 Review. French.
-
Retinoic acid receptors: involvement in acute promyelocytic leukemia.Cell Mol Biol (Noisy-le-grand). 1994 May;40(3):263-74. Cell Mol Biol (Noisy-le-grand). 1994. PMID: 7920173 Review.
Cited by
-
From Molecular to Radionuclide and Pharmacological Aspects in Transthyretin Cardiac Amyloidosis.Int J Mol Sci. 2024 Dec 27;26(1):146. doi: 10.3390/ijms26010146. Int J Mol Sci. 2024. PMID: 39796004 Free PMC article. Review.
-
Identification and characterisation of subtype-specific anti-N-CoR OSGEP protease in acute myeloid leukaemia (AML-M5) cell lineage.Biotechnol Lett. 2025 Aug 12;47(5):90. doi: 10.1007/s10529-025-03630-3. Biotechnol Lett. 2025. PMID: 40796998
-
The Unfolded Protein Response: A Novel Therapeutic Target in Acute Leukemias.Cancers (Basel). 2020 Feb 1;12(2):333. doi: 10.3390/cancers12020333. Cancers (Basel). 2020. PMID: 32024211 Free PMC article. Review.
-
Discovery of LAMP-2A as potential biomarkers for glioblastoma development by modulating apoptosis through N-CoR degradation.Cell Commun Signal. 2021 Mar 24;19(1):40. doi: 10.1186/s12964-021-00729-8. Cell Commun Signal. 2021. PMID: 33761934 Free PMC article.
-
Autophagic Degradation of Misfolded Nuclear Receptor Co-repressor (NCoR) Is Linked to the Growth of Tumor Cells in HBX Positive Hepatocellular Carcinoma (HCC).Front Oncol. 2019 Dec 3;9:1335. doi: 10.3389/fonc.2019.01335. eCollection 2019. Front Oncol. 2019. PMID: 31850220 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials